Skip to content
Newsletter
Toggle navigation
Newsletter
Search for:
Search
About angioedema
Toggle menu
What is angioedema?
Types
Acquired angioedema
Hereditary angioedema
Idiopathic angioedema
Acute allergic angioedema
Drug-induced nonallergic angioedema
Causes
Diagnosis
Symptoms
Living with angioedema
Diet
Treatments
Toggle menu
Approved treatments
Experimental treatments
Featured topics
Toggle menu
Taking action with HAE
HAE and advocacy
Next steps after an HAE diagnosis
Beyond swelling: Other HAE symptoms
Treatment and management of HAE attacks
Raising a child with HAE
HAE triggers and prevention plan
HAE and preventive treatment
Bracing for a diagnosis
HAE and stress
Angioedema and skin care
View all
Navigating HAE
HAE genetics
HAE and factor XII
Managing HAE medications
HAE and women
Traveling with HAE
HAE awareness and advocacy
Talking to your doctor
Self-care tips for caregivers
Exercise and HAE
Gut health
News
Columns
Toggle menu
Dancing with Rare Disease
— Natalie Sirota
From the Caregiver’s HAErt
— Danita LaShelle Jones
Living Rare, Speaking Loud
— Hollie Amadio
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Theme Templates, —
Articles by Theme Templates
Recent Posts
DPP4 inhibitors for type 2 diabetes found not to raise angioedema risk
FDA OKs sebetralstat, now Ekterly, as oral on-demand HAE therapy
ACE inhibitor deemed cause of woman’s intestinal angioedema
Pendopharm, Kalvista to bring sebetralstat for HAE to Canada
Voices for change in a village of rare disease advocates, part 3
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Email Address
(Required)
Email
This field is for validation purposes and should be left unchanged.
Δ
